Author

Weijin Zhang

Observed name: W. Zhang

Institution: Shantou Central Hospital

Observed institutions: Bengbu Medical College, Shantou Central Hospital

ORCID: 0009-0009-3020-3232

Observed ORCID: 0009-0009-3020-3232

OpenAlex ID: A5076023344

Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial

2020 · M. Shi, A. Gu, et al. · Annals of Oncology · 79

Hypoxia and Singlet Oxygen Dual-Responsive Micelles for Photodynamic and Chemotherapy Therapy Featured with Enhanced Cellular Uptake and Triggered Cargo Delivery

2024 · Xuliang Guo, Lefei Han, et al. · International Journal of Nanomedicine · 15

Shuang Bailian mixture enhanced the anti-cancer effect of cisplatin by regulating PI3K-Akt-Bcl 2 signaling pathway

2025 · Yilin Zheng, Xiaoyan Li, et al. · Journal of Ethnopharmacology · 3

Isolated muscular tuberculosis with secondary haemophagocytic lymphohistiocytosis

2026 · Weijin Zhang, Guangzhou Du, et al. · The Lancet Rheumatology

Works count: 4

Citation count: 97

H-index: 3

I10-index: 2